Excerpts from the United States Renal Data System, 2008 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States, National Institutes of Health NIDDK/DKUHD

被引:151
|
作者
Collins, Allan J.
Foley, Robert N.
Herzog, Charles
Chavers, Blanche
Gilbertson, David
Ishani, Areef
Kasiske, Bertram
Liu, Jiannong
Mau, Lih-Wen
McBean, Marshall
Murray, Anne
Peter, Wendy St.
Guo, Haifeng
Li, Qi
Li, Shuling
Li, Suying
Peng, Yi
Qiu, Yang
Roberts, Tricia
Skeans, Melissa
Snyder, Jon
Solid, Craig
Wang, Changchun
Weinhandl, Eric
Zaun, David
Arko, Cheryl
Chen, Shu-Cheng
Dalleska, Frederick
Daniels, Frank
Dunning, Stephan
Ebben, James
Frazier, Eric
Hanzlik, Christopher
Johnson, Roger
Sheets, Daniel
Wang, Xinyue
Forrest, Beth
Constantini, Edward
Everson, Susan
Eggers, Paul
Agodoa, Lawrence
机构
基金
美国国家卫生研究院;
关键词
D O I
10.1053/j.ajkd.2008.10.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This 20th Annual Data Report reports data through 2006. This year we present a new volume on chronic kidney disease (CKD) in the United States, estimating the population using National Health and Nutrition Examination Surveys. We also use diagnostic codes and laboratory data to estimate the population within employer group health plans, assess use of the new International Classification of Diseases, Ninth Revision, Clinical Modification CKD diagnosis codes, and report on morbidity, mortality, care during the transition to end-stage renal disease, and expenditures in patients with CKD. In 2006, a total of 110,854 patients started end-stage renal disease therapy, with the prevalent population reaching 506,256; a total of 18,052 transplantations were performed; and 151,502 patients had functioning grafts at year end. Program expenditures reached $33.5 billion, with $22.7 billion from Medicare accounting for 6.4% of total Medicare expenditures. The incident rate increased 3.4% to 360 per million-the highest in 5 years. Treatment targets are now reached by 93% of hemodialysis patients. Fistula use is 45.4% in prevalent patients, with attempted placements doubling since 1996. Catheter use continues to be a concern. Hemoglobin levels greater than 12 g/dL are common, particularly in some providers. First year mortality rates for incident hemodialysis patients have decreased for the first time in 11 years; however, pediatric patient survival has not improved. The rate of infectious hospitalizations in the first year of dialysis therapy now equals that of cardiovascular hospitalizations. The public health impact of kidney disease is larger than previously appreciated, and early detection, education, intervention, and risk-factor control are needed to address the heavy burden of cardiovascular disease and adverse events in this vulnerable population.
引用
收藏
页码:S1 / S374
页数:374
相关论文
共 50 条
  • [41] Association of restless legs syndrome and mortality in end-stage renal disease: an analysis of the United States Renal Data System (USRDS)
    DeFerio, Joseph J.
    Govindarajulu, Usha
    Brar, Amarpali
    Cukor, Daniel
    Lee, Kathleen G.
    Salifu, Moro O.
    BMC NEPHROLOGY, 2017, 18
  • [42] Association of restless legs syndrome and mortality in end-stage renal disease: an analysis of the United States Renal Data System (USRDS)
    Joseph J. DeFerio
    Usha Govindarajulu
    Amarpali Brar
    Daniel Cukor
    Kathleen G. Lee
    Moro O. Salifu
    BMC Nephrology, 18
  • [43] Geographic patterns of end-stage renal disease and kidney transplants in the Midwestern United States
    Cao, Yanjia
    Stewart, Kathleen
    Kalil, Roberto
    APPLIED GEOGRAPHY, 2016, 71 : 133 - 143
  • [44] Burden of Hypertensive Crisis in Patients With End-Stage Kidney Disease on Maintenance Dialysis: Insights From United States Renal Data System Database
    Pothuru, Suveenkrishna
    Chan, Wan-Chi
    Mehta, Harsh
    Vindhyal, Mohinder R.
    Ranka, Sagar
    Hu, Jinxiang
    Yarlagadda, Sri G.
    Wiley, Mark A.
    Hockstad, Eric
    Tadros, Peter N.
    Gupta, Kamal
    HYPERTENSION, 2023, 80 (04) : E59 - E67
  • [45] Diabetes and the risk of end-stage renal disease (ESRD) in the United States
    Tarver-Carr, ME
    Powe, NR
    Eberhardt, MS
    Brancati, FL
    DIABETES, 2000, 49 : A190 - A190
  • [46] EPIDEMIC END-STAGE RENAL-DISEASE IN THE UNITED-STATES
    MCCLELLAN, WM
    ARTIFICIAL ORGANS, 1994, 18 (06) : 413 - 415
  • [47] Spatial distribution of inequalities in end-stage renal disease in the United States
    Bilgel, Firat
    SPATIAL AND SPATIO-TEMPORAL EPIDEMIOLOGY, 2019, 30
  • [48] Characteristics and Survival of Patients with End Stage Renal Disease and Spina Bifida in the United States Renal Data System
    Ouyang, Lijing
    Bolen, Julie
    Valdez, Rodolfo
    Joseph, David
    Baum, Michelle A.
    Thibadeau, Judy
    JOURNAL OF UROLOGY, 2015, 193 (02): : 558 - 564
  • [49] Improving Mortality in End-Stage Renal Disease Due to Granulomatosis With Polyangiitis (Wegener's) From 1995 to 2014: Data From the United States Renal Data System
    Wallace, Zachary S.
    Zhang, Yuqing
    Lu, Na
    Stone, John H.
    Choi, Hyon K.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (10) : 1495 - 1500
  • [50] Introduction to the 1998 Annual Data Report of the United States renal data system
    Wolfe, RA
    Port, FK
    Webb, RL
    Bloembergen, WE
    Hirth, R
    Young, EW
    Ojo, AO
    Strawderman, RL
    Gillespie, B
    Held, PJ
    Parekh, R
    Stack, A
    Tedeschi, PJ
    Loos, E
    Hulbert-Shearon, T
    Ashby, VB
    Callard, S
    Orzol, SM
    Carroll, CC
    Wheeler, JR
    Jones, CA
    Frederick, PR
    Greer, JW
    Agodoa, LYC
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (02) : S1 - S162